Asymmetry Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.92M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.9M | Sell |
|
|||||
|
2020
Q1 | $4.44M | Buy |
|
|||||
|
2019
Q4 | $2.35M | Buy |
|
|||||
|
2019
Q3 | $1.88M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $405K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.71M | Buy |
|
|||||
|
2018
Q1 | $1.13M | Sell |
|
|||||
|
2017
Q4 | $3.29M | Sell |
|
|||||
|
2017
Q3 | $4.5M | Sell |
|
|||||
|
2017
Q2 | $4.61M | Sell |
|
|||||
|
2017
Q1 | $4.53M | Buy |
|
|||||
|
2016
Q4 | $3.34M | Sell |
|
|||||
|
2016
Q3 | $5.03M | Sell |
|
|||||
|
2016
Q2 | $4.44M | Buy |
|
|||||
|
2016
Q1 | $1.65M | Buy |
|